USCAP 2023

Celnovte Second Showcase on USCAP.

Celnovte break a leg at the 2023 USCAP with innovative leading-edged pathology diagnostic solutions！ The impressive display attracted widespread attention and discussion from pathology experts！

#celnovte #pathology #diagnostics #USCAP

More information

Details

Zhengzhou, Henan, China

Celnovte Biotechnology Co., Ltd.

Associated Trend items

mRNA diagnostic solution

ISH probe

Albumin mRNA was detected in 22 of 23 hepatocellular carcinomas (96%); all hepatoblastomas, hepatocellular adenomas, and focal nodular hyperplasias; and within the hepatoid areas of an extrahepatic malignant mixed germ cell tumor. All other hepatic and extrahepatic tumors were negative for albumin mRNA.

More information

Celnovte’s CD138(C5G6) on Automatic IHC stainer CNT360 is honored as recommendation from NordiQC

Celnovte has consistently received excellent results in the international authoritative pathology quality assessment organizations—NordiQC Immunohistochemistry.

Last year, all antibodies submitted by Celnvote for evaluation achieved exceptional results including #HER2, #ER, #PD-L1 (TPS/CPS), #CK8/18, #PSA, #CD138, #CD5, #CD10, #MSH2, #TTF1, #p40, and #p53. Celnovte is commited to providing integrated pathology diagnostic solutions and better patient care!

More information

Celnovte 2023 Launch-mIHC technology

Immnofluorescent Mutiplexings

Multiplex immunohistochemistry (IHC) is a technique used in pathology and research to simultaneously detect and visualize multiple different biomarkers within a single tissue section.This technique is often used to investigate the expression of different proteins, their interactions, and their spatial distribution within a tissue sample.

More information

Products associated

automated sample preparation system

CNT360-M1

Compare

Remove all

Compare up to 10 products